SOLVENTUM CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.61 USD | -2.52% |
|
-7.10% | 0.00% |
| May. 30 | Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target | MT |
| May. 09 | Solventum Q1 Adjusted Earnings Decline, Net Sales Increase | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Healthcare Facilities & Services
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.85B | - | - | - | - | - | |
| 87.14B | ||||||
| 75.59B | ||||||
| 26.78B | ||||||
| 17.89B | ||||||
| 16.44B |
